Skip to main content
. Author manuscript; available in PMC: 2017 Jul 31.
Published in final edited form as: Breast Cancer Res Treat. 2016 Mar 1;156(1):109–116. doi: 10.1007/s10549-016-3695-1

Table 2.

Recall rates and biopsy rates for digital breast tomosynthesis in combination with digital mammography (DBT) compared to digital mammography (DM) alone by PROSPR research center

UPenn D-BWH VT Overall Unadjusted Adjusted
DM
n=2,981
DBT
n=20,240
DM
n=74,911
DBT
n=16,775
DM
n=64,991
DBT
n=18,983
DM
n=142,883
DBT
n=55,998
n % n % p-value n % n % p-value n % n % p-value n % n % p-value OR 95% CI OR 95% CI
Recall rate* 299 10.0 1891 9.3 0.227 7000 9.3 1383 8.2 <0.0001 7585 11.7 1582 8.3 <0.0001 14884 10.4 4856 8.7 <0.0001 0.82 (0.79–0.85) 0.68 (0.65–0.71)
Biopsy rate 71 2.4 586 2.9 0.124 1452 1.9 220 1.3 <0.0001 1024 1.6 293 1.5 0.791 2547 1.8 1099 2.0 0.0074 1.10 (1.03–1.19) 0.85 (0.77–0.93)

Abbreviations: UPenn=University of Pennsylvania, D-BWH=Dartmouth-Hitchcock health system and Brigham and Women’s Hospital, VT=University of Vermont

*

Recall rate includes BIRADS 0, 3, 4, and 5 exams.

Adjusted for center, age (age 40–49, 50–59, 60–74), breast density (categories 1, 2, 3, 4), and first exam.